Mechanisms of neurovascular dysfunction in acute ischemic brain

Current Medicinal Chemistry

Volumn 21, Issue 18, 2014, Pages 2035-2042

  Terasaki, Y ^b   Liu, Y ^a,b   Hayakawa, K ^b   Pham, L D ^b   Lo, E H ^b   Ji, X ^a   Arai, K ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell cell interaction; Extracellular vesicles; Neuronal cell death; Neuroprotection; Neurovascular unit; Stroke

Indexed keywords

CHEMOKINE; CYTOKINE; FREE RADICAL; GLUTAMIC ACID; GROWTH FACTOR;

ASTROCYTE; BRAIN CELL; BRAIN ISCHEMIA; CELL INTERACTION; CEREBROVASCULAR DISEASE; EXCITOTOXICITY; GLIA; HUMAN; INFLAMMATION; MICROGLIA; NERVE CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL COMMUNICATION; CEREBROVASCULAR ACCIDENT; EXTRACELLULAR SPACE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; CELL COMMUNICATION; EXTRACELLULAR SPACE; HUMANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STROKE;

EID: 84899824036     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666131228223400     Document Type: Review

References (123)

1. Brott, T.; Bogousslavsky, J. Treatment of acute ischemic stroke. New Engl. J. Med., 2000, 343(10), 710-722.
2. Lyden, P.; Shuaib, A.; Ng, K.; Levin, K.; Atkinson, R.P.; Rajput, A.; Wechsler, L.; Ashwood, T.; Claesson, L.; Odergren, T.; Salazar-Grueso, E.; Investigators, C.-I.H.T. Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results. Stroke, 2002, 33(1), 122-128.
3. Shuaib, A.; Lees, K.R.; Lyden, P.; Grotta, J.; Davalos, A.; Davis, S.M.; Diener, H.C.; Ashwood, T.; Wasiewski, W.W.; Emeribe, U.; Investigators, S.I.T. NXY-059 for the treatment of acute ischemic stroke. New Engl. J. Med., 2007, 357(6), 562-571.
4. Lo, E.H.; Dalkara, T.; Moskowitz, M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci., 2003, 4(5), 399-415.
5. Gladstone, D.J.; Black, S.E.; Hakim, A.M.; Heart; Stroke Foundation of Ontario Centre of Excellence in Stroke, R. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke, 2002, 33(8), 2123-2136.
6. Moskowitz, M.A.; Lo, E.H.; Iadecola, C. The science of stroke: mechanisms in search of treatments. Neuron, 2010, 67(2), 181-198.
7. Kitagawa, K. CREB and cAMP response element-mediated gene expression in the ischemic brain. The FEBSJ., 2007, 274(13), 3210-3217.
8. Wang, Y.; Qin, Z.H. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis, 2010, 15(11), 1382-1402.
9. Mabuchi, T.; Kitagawa, K.; Kuwabara, K.; Takasawa, K.; Ohtsuki, T.; Xia, Z.; Storm, D.; Yanagihara, T.; Hori, M.; Matsumoto, M. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J. Neurosci., 2001, 21(23), 9204-9213.
10. Choi, D.W.; Maulucci-Gedde, M.; Kriegstein, A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci., 1987, 7(2), 357-368.
11. Kostandy, B.B. The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol. Sci., 2012, 33(2), 223-237.
12. Nishizawa, Y. Glutamate release and neuronal damage in ischemia. Life Sci., 2001, 69(4), 369-381.
13. Rossi, D.J.; Oshima, T.; Attwell, D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature, 2000, 403(6767), 316-321.
14. Anderson, C.M.; Swanson, R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia, 2000, 32(1), 1-14.
15. Martinez-Hernandez, A.; Bell, K.P.; Norenberg, M.D. Glutamine synthetase: glial localization in brain. Science, 1977, 195(4284), 1356-1358.
16. Chaudhry, F.A.; Schmitz, D.; Reimer, R.J.; Larsson, P.; Gray, A.T.; Nicoll, R.; Kavanaugh, M.; Edwards, R.H. Glutamine uptake by neurons: interaction of protons with system a transporters. J. Neurosci., 2002, 22(1), 62-72.
17. Kvamme, E.; Roberg, B.; Torgner, I.A. Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain. Neurochem. Res., 2000, 25(9-10), 1407-1419.
18. McKenna, M.C. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J. Neuroscience Res., 2007, 85(15), 3347-3358.
19. Gorovits, R.; Avidan, N.; Avisar, N.; Shaked, I.; Vardimon, L. Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Proc. Natl. Acad. Sci. USA, 1997, 94(13), 7024-7029.
20. Jabaudon, D.; Scanziani, M.; Gahwiler, B.H.; Gerber, U. Acute decrease in net glutamate uptake during energy deprivation. Proc. Natl. Acad. Sci. USA, 2000, 97(10), 5610-5615.
21. Chen, Q.; He, S.; Hu, X.L.; Yu, J.; Zhou, Y.; Zheng, J.; Zhang, S.; Zhang, C.; Duan, W.H.; Xiong, Z.Q. Differential roles of NR2Aand NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J. Neurosci., 2007, 27(3), 542-552.
22. Chen, M.; Lu, T.J.; Chen, X.J.; Zhou, Y.; Chen, Q.; Feng, X.Y.; Xu, L.; Duan, W.H.; Xiong, Z.Q. Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke, 2008, 39, (11), 3042-3048.
23. Gouix, E.; Leveille, F.; Nicole, O.; Melon, C.; Had-Aissouni, L.; Buisson, A. Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation. Mol. Cell. Neurosci., 2009, 40(4), 463-473.
24. Stobart, J.L.; Anderson, C.M. Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front. Cell. Neurosci., 2013, 7, 38.
25. Sutherland, B.A.; Papadakis, M.; Chen, R.L.; Buchan, A.M. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia. J. Physiol., 2011, 589(Pt 17), 4105-4114.
26. Dewar, D.; Underhill, S.M.; Goldberg, M.P. Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab., 2003, 23(3), 263-274.
27. Karadottir, R.; Cavelier, P.; Bergersen, L.H.; Attwell, D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature, 2005, 438(7071), 1162-1166.
28. Franklin, R.J.; Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nature reviews. Neurosci., 2008, 9(11), 839-855.
29. Emery, B. Regulation of oligodendrocyte differentiation and myelination. Science, 2010, 330(6005), 779-782.
30. Lappe-Siefke, C.; Goebbels, S.; Gravel, M.; Nicksch, E.; Lee, J.; Braun, P.E.; Griffiths, I.R.; Nave, K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet., 2003, 33(3), 366-374.
31. Griffiths, I.; Klugmann, M.; Anderson, T.; Yool, D.; Thomson, C.; Schwab, M.H.; Schneider, A.; Zimmermann, F.; McCulloch, M.; Nadon, N.; Nave, K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science, 1998, 280(5369), 1610-1613.
32. Funfschilling, U.; Supplie, L.M.; Mahad, D.; Boretius, S.; Saab, A.S.; Edgar, J.; Brinkmann, B.G.; Kassmann, C.M.; Tzvetanova, I.D.; Mobius, W.; Diaz, F.; Meijer, D.; Suter, U.; Hamprecht, B.; Sereda, M.W.; Moraes, C.T.; Frahm, J.; Goebbels, S.; Nave, K.A. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature, 2012, 485(7399), 517-521.
33. Lee, Y.; Morrison, B.M.; Li, Y.; Lengacher, S.; Farah, M.H.; Hoffman, P.N.; Liu, Y.; Tsingalia, A.; Jin, L.; Zhang, P.W.; Pellerin, L.; Magistretti, P.J.; Rothstein, J.D. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature, 2012, 487(7408), 443-448.
34. Wilkins, A.; Majed, H.; Layfield, R.; Compston, A.; Chandran, S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocytederived glial cell line-derived neurotrophic factor. J. Neurosci., 2003, 23(12), 4967-4974.
35. Mathur, B.N.; Deutch, A.Y. Rat meningeal and brain microvasculature pericytes co-express the vesicular glutamate transporters 2 and 3. Neurosci. Lett., 2008, 435(2), 90-94.
36. Sharp, C.D.; Hines, I.; Houghton, J.; Warren, A.; Jackson, T.H.t.; Jawahar, A.; Nanda, A.; Elrod, J.W.; Long, A.; Chi, A.; Minagar, A.; Alexander, J.S. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol., 2003, 285(6), H2592-2598.
37. Basuroy, S.; Leffler, C.W.; Parfenova, H. CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis. Am. J. Physiol. Cell. Physiol., 2013, 304(11), C1105-1115.
38. Ikonomidou, C.; Turski, L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol., 2002, 1(6), 383-386.
39. Cao, W.; Carney, J.M.; Duchon, A.; Floyd, R.A.; Chevion, M. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci. Lett., 1988, 88(2), 233-238.
40. Floyd, R.A.; Towner, R.A.; He, T.; Hensley, K.; Maples, K.R. Translational research involving oxidative stress and diseases of aging. Free Radic. Biol. Med., 2011, 51(5), 931-941.
41. Gouriou, Y.; Demaurex, N.; Bijlenga, P.; De Marchi, U. Mitochondrial calcium handling during ischemia-induced cell death in neurons. Biochimie, 2011, 93(12), 2060-2067.
42. Zhang, Y.; Wang, H.; Li, J.; Jimenez, D.A.; Levitan, E.S.; Aizenman, E.; Rosenberg, P.A. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12- lipoxygenase activation. J. Neurosci., 2004, 24(47), 10616-10627.
43. Lees, K.R.; Zivin, J.A.; Ashwood, T.; Davalos, A.; Davis, S.M.; Diener, H.C.; Grotta, J.; Lyden, P.; Shuaib, A.; Hardemark, H.G.; Wasiewski, W.W.; Stroke-Acute Ischemic, N.X.Y.T.T.I., NXY- 059 for acute ischemic stroke. New Engl. J. Med., 2006, 354(6), 588-600.
44. Manzanero, S.; Santro, T.; Arumugam, T.V. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochem. Int., 2013, 62(5), 712-718.
45. Lindenau, J.; Noack, H.; Possel, H.; Asayama, K.; Wolf, G. Cellular distribution of superoxide dismutases in the rat CNS. Glia, 2000, 29(1), 25-34.
46. Dringen, R.; Gutterer, J.M.; Hirrlinger, J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem., 2000, 267(16), 4912-4916.
47. Chen, Y.; Vartiainen, N.E.; Ying, W.; Chan, P.H.; Koistinaho, J.; Swanson, R.A. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J. Neurochem., 2001, 77(6), 1601-1610.
48. Bambrick, L.; Kristian, T.; Fiskum, G. Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem. Res., 2004, 29(3), 601-608.
49. Swanson, R.A.; Ying, W.; Kauppinen, T.M. Astrocyte influences on ischemic neuronal death. Curr. Mol. Med., 2004, 4(2), 193-205.
50. Alfieri, A.; Srivastava, S.; Siow, R.C.; Modo, M.; Fraser, P.A.; Mann, G.E. Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J. Physiol., 2011, 589(Pt 17), 4125-4136.
51. Shih, A.Y.; Johnson, D.A.; Wong, G.; Kraft, A.D.; Jiang, L.; Erb, H.; Johnson, J.A.; Murphy, T.H. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci., 2003, 23(8), 3394-3406.
52. Kraft, A.D.; Johnson, D.A.; Johnson, J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tertbutylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci., 2004, 24(5), 1101-1112.
53. Calkins, M.J.; Vargas, M.R.; Johnson, D.A.; Johnson, J.A. Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicol. Sci., 2010, 115(2), 557-568.
54. Bell, K.F.; Fowler, J.H.; Al-Mubarak, B.; Horsburgh, K.; Hardingham, G.E. Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. Oxid. Med. Cell. Longev., 2011, 2011, 689524.
55. Srivastava, S.; Alfieri, A.; Siow, R.C.; Mann, G.E.; Fraser, P.A. Temporal and spatial distribution of Nrf2 in rat brain following stroke: quantitation of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique. J. Physiol., 2013, 591(Pt 14), 3525-3538.
56. West, A.K.; Hidalgo, J.; Eddins, D.; Levin, E.D.; Aschner, M. Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology, 2008, 29(3), 489-503.
57. van Lookeren Campagne, M.; Thibodeaux, H.; van Bruggen, N.; Cairns, B.; Gerlai, R.; Palmer, J.T.; Williams, S.P.; Lowe, D.G. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc. Natl. Acad. Sci. USA, 1999, 96(22), 12870-12875.
58. Trendelenburg, G.; Prass, K.; Priller, J.; Kapinya, K.; Polley, A.; Muselmann, C.; Ruscher, K.; Kannbley, U.; Schmitt, A.O.; Castell, S.; Wiegand, F.; Meisel, A.; Rosenthal, A.; Dirnagl, U. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci., 2002, 22(14), 5879-5888.
59. Chung, R.S.; Penkowa, M.; Dittmann, J.; King, C.E.; Bartlett, C.; Asmussen, J.W.; Hidalgo, J.; Carrasco, J.; Leung, Y.K.; Walker, A.K.; Fung, S.J.; Dunlop, S.A.; Fitzgerald, M.; Beazley, L.D.; Chuah, M.I.; Vickers, J.C.; West, A.K. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem., 2008, 283(22), 15349-15358.
60. Sohn, E.J.; Kim, D.W.; Kim, M.J.; Jeong, H.J.; Shin, M.J.; Ahn, E.H.; Kwon, S.W.; Kim, Y.N.; Kim, D.S.; Han, K.H.; Park, J.; Hwang, H.S.; Eum, W.S.; Choi, S.Y. PEP-1-metallothionein-III protein ameliorates the oxidative stress-induced neuronal cell death and brain ischemic insults. Biochimica et Biophysica Acta, 2012, 1820(10), 1647-1655.
61. Chrissobolis, S.; Banfi, B.; Sobey, C.G.; Faraci, F.M. Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J. Appl. Physiol., 2012, 113(2), 184-191.
62. Miller, A.A.; Drummond, G.R.; Sobey, C.G. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol. Ther., 2006, 111(3), 928-948.
63. Pacher, P.; Szabo, C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am. J. Pathol., 2008, 173(1), 2-13.
64. Christov, A.; Ottman, J.T.; Grammas, P. Vascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimer's disease. Neurol. Res., 2004, 26(5), 540-546.
65. Mronga, T.; Stahnke, T.; Goldbaum, O.; Richter-Landsberg, C. Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia, 2004, 46(4), 446-455.
66. Juurlink, B.H.; Thorburne, S.K.; Hertz, L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia, 1998, 22(4), 371-378.
67. Lo, E.H. A new penumbra: transitioning from injury into repair after stroke. Nat. Med., 2008, 14(5), 497-500.
68. Hayakawa, K.; Pham, L.D.; Som, A.T.; Lee, B.J.; Guo, S.; Lo, E.H.; Arai, K. Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells. J. Neurosci., 2011, 31(29), 10666-10670.
69. Cavaliere, F.; Urra, O.; Alberdi, E.; Matute, C. Oligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate. Cell Death Dis., 2012, 3, e268.
70. Fleissner, F.; Thum, T. Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid. Redox. Signal., 2011, 15(4), 933-948.
71. Kalyanaraman, B.; Darley-Usmar, V.; Davies, K.J.; Dennery, P.A.; Forman, H.J.; Grisham, M.B.; Mann, G.E.; Moore, K.; Roberts, L.J., 2nd; Ischiropoulos, H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med., 2012, 52(1), 1-6.
72. Eltzschig, H.K.; Eckle, T. Ischemia and reperfusion-from mechanism to translation. Nat. Med., 2011, 17(11), 1391-1401.
73. Yilmaz, G.; Granger, D.N. Leukocyte recruitment and ischemic brain injury. Neuromol. Med., 2010, 12(2), 193-204.
74. Hallenbeck, J.M.; Dutka, A.J.; Tanishima, T.; Kochanek, P.M.; Kumaroo, K.K.; Thompson, C.B.; Obrenovitch, T.P.; Contreras, T.J. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke, 1986, 17(2), 246-253.
75. Clark, R.K.; Lee, E.V.; Fish, C.J.; White, R.F.; Price, W.J.; Jonak, Z.L.; Feuerstein, G.Z.; Barone, F.C. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res. Bull., 1993, 31(5), 565-572.
76. Campanella, M.; Sciorati, C.; Tarozzo, G.; Beltramo, M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke, 2002, 33(2), 586-592.
77. Shichita, T.; Ago, T.; Kamouchi, M.; Kitazono, T.; Yoshimura, A.; Ooboshi, H. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J. Neurochem., 2012, 123 Suppl 2, 29-38.
78. Graeber, M.B. Changing face of microglia. Science, 2010, 330(6005), 783-788.
79. Biber, K.; Neumann, H.; Inoue, K.; Boddeke, H.W. Neuronal 'On' and 'Off' signals control microglia. Trend. Neurosci., 2007, 30(11), 596-602.
80. Wake, H.; Moorhouse, A.J.; Jinno, S.; Kohsaka, S.; Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci., 2009, 29(13), 3974-3980.
81. Neher, J.J.; Neniskyte, U.; Brown, G.C. Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration. Front. Pharmacol., 2012, 3, 27.
82. Mott, R.T.; Ait-Ghezala, G.; Town, T.; Mori, T.; Vendrame, M.; Zeng, J.; Ehrhart, J.; Mullan, M.; Tan, J. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia, 2004, 46(4), 369-379.
83. Iadecola, C.; Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med., 2011, 17(7), 796-808.
84. Kim, J.B.; Sig Choi, J.; Yu, Y.M.; Nam, K.; Piao, C.S.; Kim, S.W.; Lee, M.H.; Han, P.L.; Park, J.S.; Lee, J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci., 2006, 26(24), 6413-6421.
85. Hayakawa, K.; Qiu, J.; Lo, E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. N. Y. Acad. Sci., 2010, 1207, 50-57.
86. Marsh, B.J.; Williams-Karnesky, R.L.; Stenzel-Poore, M.P. Tolllike receptor signaling in endogenous neuroprotection and stroke. Neurosci., 2009, 158(3), 1007-1020.
87. Okun, E.; Griffioen, K.J.; Lathia, J.D.; Tang, S.C.; Mattson, M.P.; Arumugam, T.V. Toll-like receptors in neurodegeneration. Brain Res. Rev., 2009, 59(2), 278-292.
88. Smith, J.A.; Das, A.; Ray, S.K.; Banik, N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull., 2012, 87(1), 10-20.
89. Barreto, G.; White, R.E.; Ouyang, Y.; Xu, L.; Giffard, R.G. Astrocytes: targets for neuroprotection in stroke. Cent. Nerv. Syst. Agents Med. Chem., 2011, 11(2), 164-173.
90. Sa-Pereira, I.; Brites, D.; Brito, M.A. Neurovascular unit: a focus on pericytes. Mol. Nneurobiol., 2012, 45(2), 327-347.
91. Kovac, A.; Erickson, M.A.; Banks, W.A. Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J. Neuroinflam., 2011, 8, 139.
92. Dirnagl, U. Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann. N. Y. Acad. Sci., 2012, 1268, 21-25.
93. Yilmaz, G.; Granger, D.N. Cell adhesion molecules and ischemic stroke. Neurol. Res., 2008, 30(8), 783-793.
94. Xing, C.; Hayakawa, K.; Lok, J.; Arai, K.; Lo, E.H. Injury and repair in the neurovascular unit. Neurol. Res., 2012, 34(4), 325-330.
95. Maki, T.; Hayakawa, K.; Pham, L.D.; Xing, C.; Lo, E.H.; Arai, K. Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases. CNS. Neurol. Disord. Drug Targets, 2013, 12(3), 302-315.
96. del Zoppo, G.J. The neurovascular unit, matrix proteases, and innate inflammation. Ann. N. Y. Acad. Sci., 2010, 1207, 46-49.
97. Romi, F.; Helgeland, G.; Gilhus, N.E. Serum levels of matrix metalloproteinases: implications in clinical neurology. Eur. Neurol., 2012, 67(2), 121-128.
98. Seo, J.H.; Guo, S.; Lok, J.; Navaratna, D.; Whalen, M.J.; Kim, K.W.; Lo, E.H. Neurovascular matrix metalloproteinases and the blood-brain barrier. Curr. Pharm. Des., 2012, 18(25), 3645-3648.
99. Asahi, M.; Wang, X.; Mori, T.; Sumii, T.; Jung, J.C.; Moskowitz, M.A.; Fini, M.E.; Lo, E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci., 2001, 21(19), 7724-7732.
100. Zhao, B.Q.; Wang, S.; Kim, H.Y.; Storrie, H.; Rosen, B.R.; Mooney, D.J.; Wang, X.; Lo, E.H. Role of matrix metallo proteinases in delayed cortical responses after stroke. Nat. Med., 2006, 12(4), 441-445.
101. Lodish, H.; Berk, A.; Zipursky, S.L.; Matsudaira, P.; Baltimore, D.; Darnel, J. Molecular Cell Biology, 4th edition. W.H. Freeman and Company: New York, 2000.
102. Wolf, P. The nature and significance of platelet products in human plasma. Brit. J. Haematol., 1967, 13(3), 269-288.
103. Trams, E.G.; Lauter, C.J.; Salem, N., Jr.; Heine, U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochimica et Biophysica Acta, 1981, 645(1), 63-70.
104. Camussi, G.; Deregibus, M.C.; Bruno, S.; Cantaluppi, V.; Biancone, L. Exosomes/microvesicles as a mechanism of cell-tocell communication. Kidney Int., 2010, 78(9), 838-848.
105. Lai, C.P.; Breakefield, X.O. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front. Physiol., 2012, 3, 228.
106. Ling, Z.L.; Combes, V.; Grau, G.E.; King, N.J. Microparticles as immune regulators in infectious disease - an opinion. Front. Immunol., 2011, 2, 67.
107. Shai, E.; Varon, D. Development, cell differentiation, angio genesis-microparticles and their roles in angiogenesis. Arterioscler. Thromb. Vasc. Biol. , 2011, 31(1), 10-14.
108. Tushuizen, M.E.; Diamant, M.; Sturk, A.; Nieuwland, R. Cellderived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscler. Thromb. Vasc. Biol. , 2011, 31(1), 4-9.
109. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Res., 2010, 107(6), 810-817.
110. Fruhbeis, C.; Frohlich, D.; Kramer-Albers, E.M. Emerging roles of exosomes in neuron-glia communication. Front. Physiol., 2012, 3, 119.
111. Guo, S.; Zhou, Y.; Xing, C.; Lok, J.; Som, A.T.; Ning, M.; Ji, X.; Lo, E.H. The vasculome of the mouse brain. PloS One, 2012, 7(12), e52665.
112. Bulut, D.; Maier, K.; Bulut-Streich, N.; Borgel, J.; Hanefeld, C.; Mugge, A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J. Card. Fail., 2008, 14(4), 336-340.
113. Horstman, L.L.; Jy, W.; Jimenez, J.J.; Ahn, Y.S. Endothelial microparticles as markers of endothelial dysfunction. Front. Biosci., 2004, 9, 1118-1135.
114. Deregibus, M.C.; Cantaluppi, V.; Calogero, R.; Lo Iacono, M.; Tetta, C.; Biancone, L.; Bruno, S.; Bussolati, B.; Camussi, G. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood, 2007, 110(7), 2440-2448.
115. Taraboletti, G.; D'Ascenzo, S.; Borsotti, P.; Giavazzi, R.; Pavan, A.; Dolo, V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol., 2002, 160(2), 673-680.
116. Jung, K.H.; Chu, K.; Lee, S.T.; Park, H.K.; Bahn, J.J.; Kim, D.H.; Kim, J.H.; Kim, M.; Kun Lee, S.; Roh, J.K. Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann. Neurol., 2009, 66(2), 191-199.
117. Simak, J.; Gelderman, M.P.; Yu, H.; Wright, V.; Baird, A.E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J. Thromb. Haemost., 2006, 4(6), 1296-1302.
118. Proia, P.; Schiera, G.; Mineo, M.; Ingrassia, A.M.; Santoro, G.; Savettieri, G.; Di Liegro, I. Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int. J. Mol. Med., 2008, 21(1), 63-67.
119. Wang, G.; Dinkins, M.; He, Q.; Zhu, G.; Poirier, C.; Campbell, A.; Mayer-Proschel, M.; Bieberich, E. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J. Biol. Chem., 2012, 287(25), 21384-21395.
120. Falchi, A.M.; Sogos, V.; Saba, F.; Piras, M.; Congiu, T.; Piludu, M. Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP. Histochem. Cell Biol., 2013, 139(2), 221-231.
121. Kramer-Albers, E.M.; Bretz, N.; Tenzer, S.; Winterstein, C.; Mobius, W.; Berger, H.; Nave, K.A.; Schild, H.; Trotter, J. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? Proteom. Clin. Appl., 2007, 1(11), 1446-1461.
122. Fitzner, D.; Schnaars, M.; van Rossum, D.; Krishnamoorthy, G.; Dibaj, P.; Bakhti, M.; Regen, T.; Hanisch, U.K.; Simons, M. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci., 2011, 124(Pt 3), 447-458.
123. Bakhti, M.; Winter, C.; Simons, M. Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J. Biol. Chem., 2011, 286(1), 787-796.